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Abstract
3-Amino-1,4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1), one of the tryptophan pyrolysates, is a dietary carcinogen and is
formed in cooked meat and fish in our daily diet. Trp-P-1 will affect the cells in the blood circulation system before it causes
carcinogenicity in target organs such as the liver. In this study, the cytotoxicity of Trp-P-1 was investigated in mononuclear
cells (MNCs) from blood. Trp-P-1 (10^15 WM) decreased cell viability and induced apoptosis characterized both by
morphological changes and by DNA fragmentation 4 h after treatment. DNA fragmentation was also observed following
treatment at 1 nM after 24 h in culture. This result suggested that apoptosis would occur in the body following unexpected
intake of foods containing Trp-P-1. To determine the mechanism of apoptosis, we investigated the activation of the caspase
cascade in MNCs. Trp-P-1 (10^15 WM) activated the caspase cascade, i.e. the activity of caspase-3, -6, -7, -8 and -9 increased
dose-dependently using peptide substrates, the active forms of caspase-3, -8 and -9 were detected by immunoblotting, and
cleavage of poly(ADP-ribose) polymerase and protein kinase C-N as the intracellular substrates for caspases was observed. A
peptide inhibitor of caspase-8 completely suppressed activation of all other caspases, while an inhibitor of caspase-9 did not.
These results indicated that caspase-8 may act as an apical caspase in the Trp-P-1-activated cascade. ß 2001 Elsevier
Science B.V. All rights reserved.
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1. Introduction
The tryptophan pyrolysate 3-amino-1,4-dimethyl-
5H-pyrido[4,3-b]indole (Trp-P-1) is a potent mutagen
and carcinogen present in the charred surface of
meat and ¢sh [1,2], e.g. 1 g of broiled beef was shown
to contain 0.21 ng of Trp-P-1 [3]. Since Trp-P-1 re-
quires metabolic activation catalyzed by the cyto-
chrome P-4501A subfamily for its mutagenicity and
carcinogenicity [4,5], its actions have been well
studied in the liver [2,6], but there have been few
studies in the immune system. After ingestion, Trp-
P-1 is carried to target organs such as the liver via
the blood circulatory system. When 14C-labeled Trp-
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P-1 was intravenously injected into mice, the radio-
activity was detected not only in the liver but also
throughout the whole body including the blood and
spleen [7]. Recently, we demonstrated that Trp-P-1
induced apoptosis in primary cultured rat hepato-
cytes without metabolic activation [8,9]. Thus, Trp-
P-1 will induce apoptosis in various kinds of cells in
the blood and tissues.
Apoptosis is characterized by degradation of chro-
mosomal DNA into nucleosomal units accompanied
by morphological changes in the cells [10,11]. The
caspases, a family of cysteine proteases, play a cen-
tral role in most apoptotic processes constructing the
protease cascade including the initiator caspases (cas-
pase-8 and -9) and the e¡ector caspases (caspase-3, -6
and -7) [12,13]. The caspases cleave intracellular sub-
strates such as other caspases, poly(ADP-ribose)
polymerase (PARP) and protein kinase C-N (PKC-
N) [14^16], resulting in distinct morphological and
biochemical changes [17]. There are two pathways
in the initiation step of the caspase cascade: a death
receptor-mediated pathway dominated by caspase-8
and a mitochondria-dependent pathway dominated
by caspase-9 [18,19].
The death receptor-mediated pathway is initiated
by the interaction between a ligand and its receptor
such as FasL and Fas [20], and is involved in the
activation of caspase-8. In immunocytes, this path-
way plays a physiologically important role in im-
mune responses to remove deleterious cells, e.g. pe-
ripheral deletion of activated mature T cells at the
end of the immune response and killing of virus-in-
fected cells or cancer cells by cytotoxic T and natural
killer cells [20]. On the other hand, some chemicals
such as etoposide and staurosporine induce apoptosis
via the mitochondria-dependent pathway in which
caspase-9 is initially activated [21^23]. These chemi-
cal inducers also activate caspase-8 in the absence of
death receptor signaling [24,25]. Other reports have
suggested that caspase-8 acts as an executioner in
chemical-induced apoptosis, i.e. the activation of cas-
pase-8 is not an integral part of the apoptosis [22,26].
In this study, we investigated the e¡ects of Trp-P-1
on rat mononuclear cells (MNCs) consisting lympho-
cytes and monocytes prepared from blood. We
showed that Trp-P-1 clearly induced apoptosis in
MNCs as estimated by DNA fragmentation and
morphological changes in the cells and nuclei.
DNA fragmentation was detected even at 1 nM
Trp-P-1 24 h after treatment. Furthermore, cas-
pase-8 would be dominant in the caspase cascade
by which Trp-P-1 was activated, and the activated
caspase-8 in turn resulted in the activation of down-
stream caspase-3, -6, -7 and -9. Some apoptotic
events mentioned above were observed in human
MNCs after exposure to Trp-P-1.
2. Materials and methods
2.1. Materials
Trp-P-1 acetate form was purchased from Wako
Pure Chemical Industries (Osaka, Japan) and pre-
pared as a 40 mM stock solution in dimethyl sulf-
oxide (DMSO). For the culture of rat MNCs, RPMI
1640 was purchased from Nissui Pharmaceutical
(Tokyo, Japan) and fetal bovine serum was from
Dainippon Pharmaceutical (Tokyo, Japan). For
analysis of caspases, the £uorogenic peptide sub-
strates (Ac-YVAD-MCA, Ac-DEVD-MCA, Ac-
DMQD-MCA, Ac-VEID-MCA, Ac-DQTD-MCA,
Ac-IETD-MCA and Ac-LEHD-MCA) and the pep-
tide inhibitors (Ac-IETD-CHO and Ac-LEHD-
CHO) were purchased from Peptide Institute (Osaka,
Japan) and dissolved at 10 mM in DMSO. For West-
ern blotting and immunoprecipitation analyses, the
following antibodies were used: a goat polyclonal
antibody to caspase-3 and rabbit polyclonal antibod-
ies to caspase-8, caspase-9 and PARP (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), a rabbit
polyclonal antibody to PKC-N and human speci¢c
mouse monoclonal antibodies to caspase-3 and
FADD (Transduction Laboratories, Lexington,
KY, USA), human speci¢c rabbit antibodies to cas-
pase-8 and caspase-9 (Oncogene Research Products,
Cambridge, MA, USA), and secondary antibodies to
rabbit IgG and mouse IgG (Amersham Pharmacia
Biotech, Tokyo, Japan) and to goat IgG (Wako
Pure Chemical Industries). All other chemicals were
of the highest quality commercially available.
2.2. Preparation and culture of rat MNCs
Rat MNCs were prepared from blood of male
Wistar rats (7^8 weeks old, purchased from Japan
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SLC, Shizuoka, Japan) using NycoPrep 1.077A (Ny-
comed Pharma, Oslo, Norway) [27]. Human MNCs
were also prepared from a healthy volunteer using
Lymphoprep (Nycomed Pharma). MNCs were cul-
tured at a density of 1U106 cells/ml in RPMI 1640
medium containing 5% fetal bovine serum, 1 mM
glutamine and 1 Wg/ml kanamycin in an atmosphere
of 95% air-5% CO2 at 37‡C. The cells were treated
with various concentrations of Trp-P-1 for various
times as indicated in each ¢gure. Additional dishes
were treated in parallel with the same volume of
DMSO (¢nal concentration of 0.1%) as vehicle alone
for the control samples.
2.3. Measurement of cell viability
Cell viability was determined as total mitochon-
drial dehydrogenase activity in the viable cells by
MTT assay [28]. Brie£y, MTT in PBS was added
to MNCs at a ¢nal concentration of 0.5 mg/ml and
incubated for 3 h. MTT-formazan formed was dis-
solved in isopropanol containing 0.04 N HCl by ag-
itation, and determined by measuring the absorbance
at 570 and 630 nm (for background) with a micro-
plate reader.
2.4. Analysis of apoptotic morphological changes
MNCs were cultured with 15 WM Trp-P-1 or
DMSO for 4 h, then aliquots of 5U106 cells were
washed with PBS and ¢xed with Carnoy’s ¢xative
(acetic acid:methanol 1:3). After drying, the cells
were stained with 2% Giemsa in 67 mM sodium
phosphate bu¡er (pH 6.4) or 250 WM Hoechst
33258 in PBS. Morphological changes were analyzed
under a light or a £uorescence microscope.
2.5. Analysis of DNA fragmentation
As apoptotic biomarkers, the quantitative mea-
surement of DNA fragmentation and the detection
of DNA ladder formation were performed in Trp-P-
1-treated MNCs. DNA fragmentation was measured
by a slight modi¢cation of the published method [29].
Brie£y, rat MNCs (3.5U105 cells) were lysed with
200 Wl of TE bu¡er (10 mM Tris-HCl, pH 8.0, and
1 mM EDTA) containing 0.5% Triton X-100, and
the lysates were centrifuged at 17 000Ug for 20 min
at 4‡C to separate fragmented from intact DNA. The
supernatant containing fragmented DNA was trans-
ferred to a new microtube, and the pellet containing
intact DNA was dissolved in 200 Wl of TE bu¡er
containing 0.5% SDS. Both DNA fractions were
treated with RNase A (¢nal concentration of 0.25
mg/ml) at 50‡C for 10 min and with proteinase K
(0.25 mg/ml) at 50‡C for a further 30 min. After the
addition of 0.5 M NaCl and 1 mM EGTA (¢nal
concentrations), DNA was precipitated with 50% iso-
propanol at 320‡C for 6 h. DNA was obtained by
centrifugation at 17 000Ug for 20 min and dissolved
in Tris-NaCl bu¡er (10 mM Tris-HCl, pH 7.4, 100
mM NaCl and 5 mM EDTA) containing DAPI, a
£uorescence probe for double-stranded DNA [30], at
a ¢nal concentration of 0.5 Wg/ml. The £uorescence
intensity was measured at excitation and emission
wavelengths of 350 and 452 nm, respectively. DNA
fragmentation was calculated as the ratio of the frag-
mented DNA to the sum of the intact and frag-
mented DNA.
To detect DNA ladder formation, the fragmented
DNA was separately prepared as described above,
washed with 70% ethanol and dissolved in TE bu¡er.
The DNA solution was applied to a 2% agarose gel
in TBE bu¡er (89 mM Tris, 89 mM boric acid and
2 mM EDTA). After electrophoresis, DNA was
stained with ethidium bromide and visualized under
UV light.
2.6. Assay for caspase activity
Caspase activity was measured using £uorogenic
peptide substrates as described previously [31].
Brie£y, aliquots of 3U105 of MNCs were treated
with Trp-P-1, washed with PBS, suspended in lysis
bu¡er (100 mM HEPES, pH 7.5, 10% sucrose, 0.1%
Nonidet P-40, 1 mM EDTA, 1 mM PMSF, 10 WM
leupeptin and 1 WM pepstatin), and left on ice for 30
min to allow lysis. After sonication for 10 s (Heart
System Sonicator, 10% pulse), the lysate was ob-
tained by centrifugation at 10 000Ug for 10 min at
4‡C. Aliquots of lysate were incubated in lysis bu¡er
without pepstatin at 37‡C, and the reaction started
by adding the peptide substrate (¢nal concentration
of 10 WM). The 7-amino-4-methylcoumarin (AMC)
liberated from the substrate was measured spectro-
£uorometrically at excitation and emission wave-
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lengths of 380 and 460 nm, respectively, for 4 min.
The activity was calculated as the amount of libera-
ted AMC/min/mg protein and represented as % of
activity from the control cells.
To investigate the e¡ects of the peptide inhibitor
on the initiator caspases, MNCs were preincubated
with Ac-IETD-CHO for caspase-8 or Ac-LEHD-
CHO for caspase-9 for 1 h. The cells were cultured
for a further 3 h with Trp-P-1 and used for the assay
of the caspase activity as described above or for im-
munoblotting to detect the active forms of caspase-3,
-8 and-9 as follows.
2.7. Western blotting analysis of caspases, PARP and
PKC-N
MNCs treated with Trp-P-1 were washed with
PBS, suspended in TE bu¡er containing 0.5% Triton
X-100, and centrifuged at 2000Ug for 10 min at 4‡C.
The pellet containing nuclei was mixed with RIPA
bu¡er (50 mM Tris-HCl, pH 7.2, 150 mM NaCl, 1%
Nonidet P-40, 1% sodium deoxycholic acid and
0.05% SDS) to allow lysis, and the mixture was cen-
trifuged at 17 000Ug for 10 min at 4‡C following
three cycles of freezing and thawing using liquid ni-
trogen. The supernatant was collected as the nuclear
protein extracts and subjected to Western blotting
analysis of caspase-3 and PARP. For analysis of cas-
pase-8 and -9 and PKC-N, whole-cell lysate was pre-
pared by addition of RIPA bu¡er to MNCs. Each
protein sample was solubilized in SDS-treatment
bu¡er (62.5 mM Tris-HCl, pH 6.8, 1% SDS, 11%
glycerol, 0.004% bromophenol blue and 5% 2-mer-
captoethanol) and boiled at 100‡C for 5 min. Ali-
quots of 40 Wg of nuclear proteins or 60 Wg proteins
of whole-cell lysate were separated by SDS-polyac-
rylamide gel electrophoresis and transferred to poly-
(vinylidene di£uoride) membranes. During electro-
phoresis tricine bu¡er was used for the detection of
small molecular subunits of caspases. The mem-
branes were blocked with 5% fetal bovine serum in
TBST bu¡er (10 mM Tris-HCl, pH 8.0, 150 mM
NaCl and 0.05% Tween 20) for 1 h, washed with
TBST bu¡er four times for 5 min each time, and
then incubated with respective primary antibodies
for 1 h. After washing of the membrane under the
same conditions, the blots were treated with the cor-
responding secondary antibody conjugated with
horseradish peroxidase for 30 min. The immune
complexes were detected by enhanced chemilumines-
cence using an ECL plus kit (Amersham Pharmacia
Biotech). After the Western blotting analysis, the
membranes were stained with Coomassie brilliant
blue R-250 to check whether they had the same
amount of protein in each sample (data not shown).
2.8. Measurement of reactive oxygen species (ROS)
To investigate the involvement of ROS in Trp-P-1-
induced apoptosis, we introduced 2P,7P-dichloro£uor-
escein diacetate (DCFH-DA) as a cell-permeable
non-£uorescent probe [32]. MNCs were pretreated
with 100 WM DCFH-DA with or without 25 mM
N-acetylcysteine (NAC) for 1 h, and incubated with
various concentrations of Trp-P-1 for another 1 h.
The cells were washed with cold PBS and resus-
pended in 1 ml of PBS. Formed £uorescent 2P,7P-
dichloro£uorescein upon oxidation was measured
spectro£uorometrically at excitation and emission
wavelengths of 495 and 530 nm, respectively. Data
were expressed as an arbitrary unit of £uorescent
intensity.
Fig. 1. Reduction of cell viability in Trp-P-1-treated rat MNCs.
MNCs were treated with various concentrations of Trp-P-1 for
4 h (A) or with 15 WM Trp-P-1 for the indicated times (B).
Control cells were treated with the same volume of DMSO as
vehicle alone (¢nal concentration of DMSO was 0.1%). After
culture, cell viability was measured by MTT assay as described
in Section 2 and then calculated as % of viability of the control
cells. Data are expressed as means þ S.D. (n = 5).
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3. Results
3.1. Cytotoxic actions of Trp-P-1 against rat MNCs
To investigate the cytotoxic e¡ects of Trp-P-1 on
MNCs, the cells were cultured with various concen-
trations of Trp-P-1 for 4 h, and cell viability was
measured by MTT assay (Fig. 1A). Trp-P-1 de-
creased the viability of MNCs in a dose-dependent
manner, and the 50% lethal toxic dose (LD50) for 4 h
was 15 WM. When the cells were treated with 15 WM
Trp-P-1 for various times, the decrease in cell viabil-
ity was time-dependent (Fig. 1B), and the time for
the 50% decrease in cell viability (t1=2) was 4 h. Thus,
Trp-P-1 showed cytotoxicity against MNCs in a
time- and dose-dependent manner.
3.2. Morphological changes following
Trp-P-1-induced cell death
Our previous study indicated that the cytotoxic
action of Trp-P-1 against rat hepatocytes was due
to the induction of apoptosis [8,9]. Thus, we ana-
lyzed morphological changes to clarify whether
Trp-P-1-induced cytotoxicity against MNCs was
also involved in apoptosis. Rat MNCs were treated
with 15 WM Trp-P-1 for 4 h, stained with Giemsa
(Fig. 2 top panels) or Hoechst 33258 (Fig. 2 middle
panels), and analyzed under a light or a £uorescence
microscope, respectively. Morphological changes in
MNCs were observed; Trp-P-1 caused cell shrinkage,
condensation of chromatin (top-right panel) and nu-
clear fragmentation (middle-right panel). Human
MNCs were also stained with Hoechst 33258 after
exposure to 100 nM Trp-P-1 for 8 h (bottom panels).
Trp-P-1 caused nuclear fragmentation in human
MNCs at the lower concentration (bottom-right pan-
el). In contrast, control cells treated with DMSO
were rounded in shape and of a constant size (left
panels), indicating that they were normal and vital.
3.3. E¡ects of Trp-P-1 on DNA fragmentation in rat
MNCs
Since DNA fragmentation is one of the biochem-
ical hallmarks of apoptosis [29], we examined the
occurrence of DNA fragmentation in MNCs treated
with various concentrations of Trp-P-1 for 4 h. Flu-
orospectrophotometric assay using DAPI indicated
that DNA fragmentation increased dose-dependently
(Fig. 3A), reaching a maximal level of about 40% at
15 WM Trp-P-1, and decreasing at 20 WM. In addi-
tion, the DNA fragmentation increased in a time-de-
pendent manner at 10 WM Trp-P-1 (Fig. 3B). DNA
fragments during apoptosis are sized in mononucleo-
somal units and appear as a ladder on agarose gel
electrophoresis [30]. Our results demonstrated that
DNA ladder formation was dose- and time-depen-
dent in Trp-P-1-treated MNCs (Fig. 3C,D). The in-
tensity of DNA ladder formation was proportionate
Fig. 2. Morphological changes in Trp-P-1-treated MNCs. Rat
MNCs were treated with 10 WM Trp-P-1 (right panels) or
DMSO as controls (left panels) for 4 h. After staining with
Giemsa (top panels) or Hoechst 33258 middle panels), morpho-
logical changes were analyzed with a light and a £uorescence
microscope, respectively. Human MNCs (bottom panels) were
also treated with 100 nM Trp-P-1 (right panel) or DMSO (left
panel) for 8 h, and stained with Hoechst 33258. Original magni-
¢cation: rat MNCs, U100; human MNCs, U200.
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to the increase in DNA fragmentation at concentra-
tions less than 15 WM Trp-P-1 (compare with Fig.
3A,C). We also detected DNA ladder formation at
low concentrations of Trp-P-1 (1^100 nM) in long-
term culture (Fig. 3E). At the high concentration of
20 WM, however, no DNA ladder formation was
observed (Fig. 3C), although cell death occurred
(Fig. 1A). Thus, Trp-P-1 induced apoptosis in
MNCs at lower concentrations.
3.4. Activation of caspases during Trp-P-1-induced
apoptosis in rat MNCs
The involvement of caspases in Trp-P-1-induced
Fig. 3. Trp-P-1-induced DNA fragmentation in rat MNCs.
MNCs were treated with various concentrations of Trp-P-1 for
4 h (A,C) or with 10 WM Trp-P-1 for the indicated times (B,D).
Control cells were treated with the same volume of DMSO as
vehicle alone. (A,B) DNA fragmentation was quanti¢ed as de-
scribed in Section 2, and data are expressed as means þ S.D.
(n = 3). (C,D) DNA ladder formation was also analyzed by 2%
agarose gel electrophoresis. M represents 100 bp DNA marker.
The data shown are representative of duplicate experiments. (E)
MNCs were treated with lower concentrations (1, 10 and 100
nM) of Trp-P-1 for 24 h, and DNA ladder formation was ana-
lyzed as described above.
6
Fig. 4. E¡ects of Trp-P-1 on the activities of caspase-1- and -3-
like proteases in rat MNCs. MNCs were treated with 15 WM
Trp-P-1 for the indicated times (A) or with various concentra-
tions of Trp-P-1 for 3 h (B). Control cells were treated with the
same volume of DMSO as vehicle alone. The cells were lysed,
and the activities of caspase-1- (a) and -3-like (b) proteases
were measured in the lysates using £uorogenic peptide sub-
strates, Ac-YVAD-MCA and Ac-DEVD-MCA, respectively, as
described in Section 2. The values are presented as % of the ac-
tivity of control cells, and data are expressed as means þ S.D.
(n = 3).
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apoptosis was determined by measuring the activities
of caspase-1- and -3-like proteases using the peptide
substrates Ac-YVAD-MCA and Ac-DEVD-MCA,
respectively. Trp-P-1 (15 WM) increased the activity
of caspase-3-like proteases in a time-dependent man-
ner (Fig. 4A). The increased activity was detected at
10^20 WM Trp-P-1 3 h after treatment (Fig. 4B). In
contrast, the caspase-1-like activity did not increase
in this study (Fig. 4A,B).
We further investigated the dose-dependent e¡ects
of Trp-P-1 on the activities of caspase-3, -6, -7, -8
and -9 using their corresponding substrates, Ac-
DMQD-MCA, Ac-VEID-MCA, Ac-DQTD-MCA,
Ac-IETD-MCA and Ac-LEHD-MCA, respectively.
Trp-P-1 increased the activity of all caspases in
MNCs 3 h after treatment (Fig. 5), and the highest
activity of each caspase was detected at 10^15 WM
Trp-P-1.
To con¢rm the activation of caspases, cleavage of
PARP and PKC-N as intracellular substrates was an-
alyzed in MNCs 4 h after treatment with 15 WM Trp-
P-1. As shown in Fig. 6 (upper panel), the 116 kDa
full-length PARP decreased as the 85 kDa fragment
increased consistently in nuclear protein extracts
from Trp-P-1-treated cells. We also detected the
cleavage of the 78 kDa PKC-N into the 40 kDa cata-
lytic fragment in whole-cell lysate (Fig. 6 lower pan-
Fig. 5. Trp-P-1 activates caspase-3, -6, -7, -8 and -9 in rat
MNCs. MNCs were treated with various concentrations of Trp-
P-1 for 3 h and lysed. The activities of caspase-3, -6, -7, -8 and
-9 were measured using corresponding peptide substrates, Ac-
DMQD-MCA, Ac-VEID-MCA, Ac-DQTD-MCA, Ac-IETD-
MCA and Ac-LEHD-MCA, respectively, as described in Fig. 4.
The values are represented as % of the activity from control
cells, and data are expressed as means þ S.D. (n = 3).
Fig. 6. Cleavage of PARP and PKC-N in Trp-P-1-treated rat
MNCs. MNCs were treated with 15 WM Trp-P-1 or DMSO as
a control for 4 h. Western blotting analyses for PARP (upper
panel) and PKC-N (lower panel) were performed using nuclear
protein extracts and whole-cell lysate, respectively, as described
in Section 2. (Upper panel) The 116 kDa full-length and the 85
kDa fragment of PARP were detected. (Lower panel) The 78
kDa full-length and the 40 kDa catalytic fragment of PKC-N
were detected. The data shown are representative of triplicate
experiments.
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el). These results suggested that Trp-P-1 activates
caspases, and activated caspases in turn cleave
PARP and PKC-N in MNCs during culture.
3.5. Role of caspase-8 and -9 in Trp-P-1-activated
cascade
To de¢ne which caspase dominates the Trp-P-1-
activated caspase cascade, we introduced two inhib-
itors, Ac-IETD-CHO and Ac-LEHD-CHO, against
caspase-8 and -9, respectively, and measured the ac-
tivities of the other caspases. Pretreatment of rat
MNCs with Ac-IETD-CHO (50 WM for 1 h) com-
pletely suppressed the increases in the activities of all
caspases (i.e. caspase-3, -6, -7, -8 and -9) to the con-
trol levels (Fig. 7). Ac-LEHD-CHO also partially
decreased but did not completely abolish these activ-
ities (Fig. 7).
Since peptide inhibitors showed cross-inhibition of
other caspases [33], we con¢rmed the activation of
caspases by Western blotting in both human and rat
MNCs pretreated with a low concentration of Ac-
IETD-CHO (10 WM) or Ac-LEHD-CHO (10 WM).
The level of p20 subunit of caspase-8 increased 3 h
after treatment with 10 WM Trp-P-1 although the
intact form did not decrease (Fig. 8 top panels).
The increase in p20 subunit was expectedly sup-
pressed by Ac-IETD-CHO but not by Ac-LEHD-
CHO. On the other hand, the activated p10 subunit
of caspase-9 by Trp-P-1 was almost disappeared by
both inhibitors (middle panels). These results indi-
cated that caspase-8 existed upstream from caspase-
9. In the case of caspase-3, we determined an accu-
mulation of the p20 active subunit in nuclear protein,
and observed that Trp-P-1 increased the accumula-
tion (bottom panels). Ac-IETD-CHO reduced this
accumulation to the control level, while Ac-LEHD-
CHO did not decrease completely, suggesting that
caspase-3 was activated mainly by the caspase-8-
mediated pathway and partly by the caspase-9-medi-
ated pathway. Thus, we con¢rmed that Trp-P-1 ac-
tivated the caspase cascade, and that caspase-8 func-
tioned as an apical caspase in this cascade.
3.6. Involvement of ROS in Trp-P-1-induced apoptosis
Since alteration of redox signaling by ROS is in-
volved in apoptosis [34], we investigated the involve-
ment of ROS in MNCs 1 h after treatment with Trp-
P-1. Trp-P-1 increased the ROS production dose-de-
pendently, and NAC completely depressed the ROS
production below the control level (Fig. 9A). In ad-
dition, the activated caspase-3-like activity by Trp-P-
1 was partly decreased by pretreatment with NAC
(Fig. 9B). These results suggested that Trp-P-1 di-
rectly or indirectly produced ROS upstream from
the caspase cascade.
4. Discussion
In the present study, we demonstrated that Trp-P-
1 induced apoptosis in rat MNCs, even at a concen-
tration of 1 nM after 24 h in culture (Fig. 3). The
Fig. 7. E¡ect of inhibitors of the initiator caspase on the Trp-
P-1-activated cascade. MNCs were pretreated with 50 WM Ac-
IETD-CHO (caspase-8 inhibitor) or 50 WM Ac-LEHD-CHO
(caspase-9 inhibitor) for 1 h, and then treated with 10 WM Trp-
P-1 or DMSO as a control for 3 h. The activities of caspase-3,
-6, -7, -8 and -9 in the cells were measured as described in Fig.
4. The values are presented as % of the activity of control cells,
and data are expressed as means þ S.D. (n = 3).
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experiments using peptide substrates showed that
caspase-3, -6, -7, -8 and -9 were activated (Fig. 5),
but that the caspase-1-like proteases (caspase-1 and
-4) were not (Fig. 4). Western blotting analysis con-
¢rmed activation of the caspase cascade (Fig. 8) and
cleavage of PARP and PKC-N, which are intracellu-
lar substrates for caspases (Fig. 6). Furthermore, we
showed the possibility of a dominating role of cas-
pase-8 in the Trp-P-1-activated caspase cascade
(Figs. 7 and 8), and indicated that the production
of ROS is involved in this apoptosis (Fig. 9). Our
previous studies [8,9] demonstrated that Trp-P-1 in-
Fig. 8. Western blotting analyses of active caspase-8, -9 and -3 in MNCs. Both human (left panels) and rat (right panels) MNCs were
separately treated with 10 WM Trp-P-1 or DMSO as a control for 3 h. The cells were pretreated with 10 WM Ac-IETD-CHO or 10
WM Ac-LEHD-CHO 1 h before addition of Trp-P-1. Active subunit (closed arrow) and intact form (open arrow) of each caspase
were detected by immunoblotting as described in Section 2. The data shown are representative of duplicate experiments.
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duced apoptosis accompanied by reduction of cell
viability in primary cultured rat hepatocytes, and
this e¡ect was observed at Trp-P-1 concentrations
of at least 10 WM. The results of this study indicated
that MNCs were more sensitive to the cytotoxicity of
Trp-P-1 than hepatocytes.
It is an interesting issue whether Trp-P-1-induced
apoptosis is involved in its carcinogenicity. Hetero-
cyclic amine type dietary carcinogens including Trp-
P-1 require microsomal activation catalyzed by cyto-
chrome P-450s, and the activated compounds cause
mutagenicity and carcinogenicity [2,35,36]. There-
fore, the carcinogenic targets of heterocyclic amines
are mainly the liver, kidney and intestine, which con-
tain abundant P-450s. In contrast, tissues and cells of
the immune system are not the main target for the
carcinogenicity, because the amounts of P-450s, es-
pecially the inducible types such as P-4501A and 2B,
are low. Indeed, Trp-P-1-induced sister-chromatid
exchanges in human lymphocytes require a metabolic
activation system (rat liver S9 mix) [37]. Even in he-
patocytes, the apoptotic action is speci¢c for trypto-
phan pyrolysis products, Trp-P-1 and Trp-P-2 [8].
Other heterocyclic amines such as PhIP and IQ
show very weak apoptotic e¡ects, although they are
as potent carcinogens as Trp-P-1. These results sug-
gested that Trp-P-1-induced apoptosis is independent
of its carcinogenicity. Trp-P-1 interacts with DNA
without microsomal activation [38], and this interac-
tion may be an apoptotic stimulus. In MNCs, we do
not have any information about Trp-P-1 interacting
with DNA as an initial stimulus for apoptosis, but at
least Trp-P-1 is distributed in various tissues, not
only the liver but also the blood and tissues for the
endocrine and immune systems after injection [7].
Furthermore, Trp-P-1 is incorporated into rat pheo-
chromocytoma PC12h cells by the dopamine uptake
system [39], and monoamine transporters are gener-
ally distributed to human lymphocytes [40,41]. We
also con¢rmed that Trp-P-1 was rapidly incorpo-
rated into rat splenocytes and thymocytes through
monoamine transporters (data not shown). Thus,
Trp-P-1 will be incorporated into and a¡ect MNCs.
Our results clearly showed that Trp-P-1 even at 1 nM
caused apoptosis in rat MNCs (Fig. 3E). Further
studies are needed to make clear whether Trp-P-1
at the physiological level induces apoptosis in vivo.
Our results showed that Trp-P-1 at less than 15
WM induced DNA fragmentation and activated cas-
pases dose-dependently, but these apoptotic events
were not observed at 20 WM (Fig. 3A,C). In contrast,
Trp-P-1 killed the cells in a dose-dependent manner
(Fig. 1A). Thus, the high concentration (20 WM) of
Trp-P-1 appeared to induce necrosis in MNCs. The
Fig. 9. Involvement of ROS in Trp-P-1-induced apoptosis. (A)
Human MNCs were pretreated with or without 25 mM N-ace-
tylcysteine (NAC) and then treated with various concentrations
of Trp-P-1 for 1 h. The production of ROS was measured using
2P,7P-dichloro£uorescein diacetate as described in Section 2. (B)
Rat MNCs were pretreated with 25 mM NAC 1 h before the
addition of 10 WM Trp-P-1 and incubated another 3 h. The ac-
tivity of caspase-3-like proteases was measured as described in
Fig. 4. Data are expressed as means þ S.D. (n = 3).
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neurotoxin 6-hydroxydopamine induces apoptosis in
PC12 cells at a low concentration (25 WM), whereas
an increased concentration of 50 WM results in a
mixture of apoptosis and necrosis [42]. The reversible
thiol oxidant diamide induces apoptosis accompa-
nied by the activation of caspase-3 at 150^200 WM,
while diamide at 500 WM induces necrosis without
activation [43]. Hydrogen peroxide at 50 mM induces
apoptosis in Jurkat T-cells with caspase activation,
and a higher concentration causes necrosis without
caspase activation [44]. Thus, the decision of cell
death, i.e. apoptosis or necrosis, may depend on
the concentration of chemical inducers related to
the intracellular redox status as reviewed recently
[45]. The decision of cell death is deeply involved in
the alteration of the levels of ROS [43,44], i.e. a small
amount of ROS induces apoptosis and a large
amount of ROS causes necrosis. Our results clearly
demonstrated that the production of ROS is con-
cerned in Trp-P-1-induced apoptosis upstream from
the caspase cascade (Fig. 9). This suggests that Trp-
P-1 alters redox signaling as an initiation step of ap-
optosis.
Caspases have distinct roles in apoptosis and in-
£ammation [46]; caspase-2, -3, -6, -7, -8, -9 and -10
are involved in apoptosis [12], whereas caspase-1 and
-4 are involved in in£ammation because of the pro-
duction of cytokines such as interleukin-1 and -18
[47,48]. Fas-mediated apoptosis is accompanied by
the activation of not only caspase-3-like proteases
(caspase-3 and -7) but also of caspase-1-like pro-
teases (caspase-1 and -4) [49]. Since Fas-mediated
apoptosis is known to be an immune response
against invasion by non-self antigens, it may cause
an in£ammatory response via caspase-1-like activity.
In contrast to these results, our observations indi-
cated that Trp-P-1 increased caspase-3-like but not
caspase-1-like activity (Fig. 4). Similarly, various
chemical inducers of apoptosis such as etoposide
and staurosporine cause the activation of caspase-3-
like but not caspase-1-like proteases [23,24]. The in-
teraction between Fas and FasL activates caspase-8
as an initiator caspase [18], and etoposide and stau-
rosporine also activate caspase-8 through a Fas-in-
dependent pathway [24,25]. The results of the present
study are consistent with the reports that Trp-P-1
also activates caspase-8 (Figs. 5 and 8). In addition,
neither caspase-8 nor FADD detected immunopreci-
pitated proteins by anti-FADD or anti-caspase-8 in
MNCs treated with Trp-P-1 (data not shown). We,
therefore, suggested that Trp-P-1-induced apoptosis
is not mediated by the death receptor-mediated path-
way, but it still remains a question how Trp-P-1 ac-
tivates caspase-8. When immunoprecipitated caspase-
8 was incubated with Trp-P-1, no active subunit of
caspase-8 was detected by Western blotting analysis
(data not shown). One possible clue is the production
of ROS (Fig. 9), and a small amount of ROS may
trigger the activation of caspase-8 directly or indi-
rectly. Each activated caspase cleaves various corre-
sponding substrates and results in subsequent mor-
phological and biochemical changes characteristic of
apoptosis. Our results showed that caspase-8 may
dominate the caspase cascade in Trp-P-1-induced ap-
optosis in MNCs although caspase-9 was also acti-
vated (Figs. 7 and 8), although the dominating role
of caspase-8 is not convincingly shown. A signal
transmitted from activated caspase-8 is bifurcated
into two pathways: direct activation of caspase-3
[17] and the mitochondria-mediated caspase cascade
[23]. In the mitochondria-mediated cascade, Bid is a
substrate of caspase-8 and is involved in the release
of cytochrome c from mitochondria into the cytosol
[50^52] followed by the activation of caspase-9 with
Apaf-1 [53,54]. The activated caspase-9 in turn acti-
vates caspase-3 as an executioner [55]. Thus, the cas-
pase-9 activated by Trp-P-1 will function down-
stream from caspase-8 and upstream from caspase-3.
As to the e¡ector caspases and their related events,
our results showed that Trp-P-1 activated caspase-3,
-6 and -7, and subsequently cleaved PARP and PKC-
N (Figs. 5, 6 and 8). In addition, Trp-P-1 induced
caspase-mediated events such as DNA fragmenta-
tion, cellular and nuclear shrinkage, and nuclear
fragmentation (Figs. 2 and 3). Activated caspase-8
induces the processing of caspase-7 [56], and cas-
pase-7 mainly mediates extranuclear changes such
as cell shrinkage [17]. Caspase-3 is directly and/or
indirectly activated by caspase-8 [17] and plays major
roles in the induction of nuclear events such as DNA
fragmentation [57,58] and chromatin condensation
[16] in contrast to the actions of caspase-7. More-
over, activated caspase-3 cleaves various intracellular
substrates including PARP and PKC-N [15,16].
PARP has been implicated in DNA repair and ge-
nome surveillance and integrity [59]. Cleavage of
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PARP causes loss of the ability to coordinate subse-
quent repair and genome maintenance events [14],
followed by DNA fragmentation by apoptotic stim-
uli. PKCs play an important role in cellular re-
sponses through the protein phosphorylation path-
ways. Cleavage of PKC-N is associated with
chromatin condensation and nuclear fragmentation
[16]. Among isozymes of PKC, rapid translocation
of PKC-N from cytosol to membrane was observed
during radiation-induced apoptosis in normal mouse
epidermal cells [60], indicating that PKC-N is the
most sensitive isozyme in apoptosis. Furthermore,
caspase-3 activates caspase-6 [17], which in turn
causes nuclear shrinkage and nuclear fragmentation
[61]. It is now recognized that di¡erent caspase cas-
cades exist in each cell type and in each death-induc-
tive stimulus [62].
It is still unclear whether Trp-P-1-induced apopto-
sis is advantageous or disadvantageous in mammals.
If Trp-P-1-induced apoptosis is advantageous, it may
be one of the host defense systems, because it pro-
vides a mechanism for elimination of cells exposed to
Trp-P-1 before manifestation of its carcinogenicity.
On the other hand, if this apoptosis is disadvanta-
geous, it may cause some diseases such an immuno-
de¢ciency. Further studies are needed to clarify these
e¡ects of Trp-P-1 in MNCs.
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